Skip to main content

Advertisement

Figure 2 | BMC Medical Genetics

Figure 2

From: Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib

Figure 2

(a) Molecular modeling of the extracellular, soluble portion of rat FasL. The soluble rat FasL trimer fragment was visualized based on the structure of TNF-α [33]. The Pt 86 FasL mutation is labeled in red and the hgld mutation is labeled in blue in side (left) and front (right) projections. The Pt 55C FasL mutation is not indicated in this model since it is located in the transmembrane domain, which is outside of the region in the model depicted. (b) A diagram of cloning strategy for epitope-tagging Fas-ligand protein.

Back to article page